Search

Your search keyword '"Geisbert, Thomas W."' showing total 1,084 results

Search Constraints

Start Over You searched for: Author "Geisbert, Thomas W." Remove constraint Author: "Geisbert, Thomas W."
1,084 results on '"Geisbert, Thomas W."'

Search Results

207. A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge

208. Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization

209. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates

210. Pathogenesis of lassa fever in cynomolgus macaques

211. Interferon-[beta] 1a and SARS coronavirus replication

213. Colaboradores

216. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.

217. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection.

218. A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green Monkeys.

219. An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys.

221. Two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates

224. Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates

225. Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever

226. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates

227. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge

230. siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease

235. Contributors

236. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins

237. Establishment of an African green monkey model for COVID-19 and protection against re-infection

240. Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

243. Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses

244. Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody

245. Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo

250. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection

Catalog

Books, media, physical & digital resources